 rationale implementation novel therapies based hallmarks cancer. Two novel compounds labelled thioglycoside B designed evaluated breast colon cancer cell lines. assessed cytotoxic effect sensitizing cancer cells insulin. order explore underlying mechanisms, performed tests assess cell migration motility, apoptosis, expression glucose transporter 1 proapoptotic proteins. compounds proved antitumor effect significantly enhanced combination insulin. Linking glucose anticancer agent presents approach exploits Warburg effect. Targeting dysfunctional glycometabolism increased glucose absorption emerging promising anticancer strategy.